Please enable JavaScript to continue using this application.

Compare $AGEN vs $ZNTL | Chartloom

Compare

$AGEN vs $ZNTL

Agenus Inc · Zentalis Pharmaceuticals Inc

AGEN

Agenus Inc

ZNTL

Zentalis Pharmaceuticals Inc

Compare $AGEN vs $ZNTL

Comparing Agenus Inc and Zentalis Pharmaceuticals Inc

AGENAgenus Inc

ZNTLZentalis Pharmaceuticals Inc

AGENAgenus Inc

Market cap

$319M

P/E (TTM)

3.45x

Forward P/E (NTM)

—

Forward P/S (NTM)

3.37x

Rev growth (TTM)

30.5%

YTD performance

137.5%

52W performance

83.9%

FCF yield

-30.8%

ZNTLZentalis Pharmaceuticals Inc

Market cap

$188M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

92.7%

52W performance

61.0%

FCF yield

-68.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AGEN

ZNTL

Detailed metrics comparison

AGEN

Agenus Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

AGEN$319M

ZNTL$188M

Enterprise Value

AGEN$580M

ZNTL$163M

Price

AGEN$7.67

ZNTL$2.64

P/E Ratio

AGEN3.45x

ZNTLN/A

P/S Ratio

AGEN2.41x

ZNTL0.00x

EV/Sales

AGEN4.37x

ZNTL0.00x

EV/EBITDA

AGEN13.66x

ZNTL0.00x

P/B Ratio

AGEN110.53x

ZNTL1.70x

P/FCF Ratio

AGENN/A

ZNTLN/A

EV/FCF

AGEN-5.89x

ZNTL-1.27x

PEG Ratio

AGENN/A

ZNTLN/A

Forward P/E (NTM)

AGENN/A

ZNTLN/A

Forward P/S (NTM)

AGEN3.37x

ZNTLN/A

Revenue (TTM)

AGEN$133M

ZNTL$0

Revenue Growth (YoY)

AGEN30.5%

ZNTLN/A

Forward Rev Growth

AGEN-1.2%

ZNTL447.5%

Gross Margin (TTM)

AGEN99.5%

ZNTL0.0%

Operating Margin (TTM)

AGEN103.2%

ZNTL0.0%

EBITDA Margin (TTM)

AGEN30.6%

ZNTL0.0%

Net Margin (TTM)

AGEN69.2%

ZNTL0.0%

FCF Margin (TTM)

AGEN-74.2%

ZNTLN/A

Net Income (TTM)

AGEN$92M

ZNTL$-62M

FCF (TTM)

AGEN$-99M

ZNTL$-128M

EPS (TTM)

AGEN$2.22

ZNTL$0.00

ROE (TTM)

AGEN76.6%

ZNTL-5277.0%

ROA (TTM)

AGEN44.9%

ZNTL-4055.0%

ROIC (TTM)

AGEN48.7%

ZNTL-5277.0%

Cash

AGEN$19M

ZNTL$25M

Debt

AGEN$280M

ZNTL$0

Net Cash/Debt

AGEN$-261M

ZNTL$25M

Current Ratio (TTM)

AGEN0.34x

ZNTL4.82x

Quick Ratio (TTM)

AGEN0.33x

ZNTL4.64x

Debt/Equity (TTM)

AGEN4.01x

ZNTL0.00x

Debt/Assets (TTM)

AGEN0.0%

ZNTL0.0%

Interest Coverage (TTM)

AGENN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

ZNTL0.00x

Beta

AGEN1.50

ZNTL1.92

52W Performance

AGEN83.9%

ZNTL61.0%

YTD Performance

AGEN137.5%

ZNTL92.7%

% from 52W High

AGEN-25.6%

ZNTL-62.0%

% from 52W Low

AGEN183.0%

ZNTL117.8%

Asset Turnover (TTM)

AGEN0.65x

ZNTL0.00x

FCF Yield (TTM)

AGEN-30.8%

ZNTL-68.2%

Earnings Yield (TTM)

AGEN28.7%

ZNTL-32.9%

Dividend Yield (TTM)

AGENN/A

ZNTLN/A

Rule of 40

AGEN-43.8

ZNTL0.0

EV/GP/RG

AGENN/A

ZNTLN/A

Ticker research

View AGEN research View ZNTL research

Metric	AGEN Agenus Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$319M	$188M
Enterprise Value	$580M	$163M
Price	$7.67	$2.64
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	0.00x
EV/Sales	4.37x	0.00x
EV/EBITDA	13.66x	0.00x
P/B Ratio	110.53x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	N/A
Revenue & Growth
Revenue (TTM)	$133M	$0
Revenue Growth (YoY)	30.5%	N/A
Forward Rev Growth	-1.2%	447.5%
Profitability
Gross Margin (TTM)	99.5%	0.0%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	0.0%
Net Margin (TTM)	69.2%	0.0%
FCF Margin (TTM)	-74.2%	N/A
Net Income (TTM)	$92M	$-62M
FCF (TTM)	$-99M	$-128M
EPS (TTM)	$2.22	$0.00
ROE (TTM)	76.6%	-5277.0%
ROA (TTM)	44.9%	-4055.0%
ROIC (TTM)	48.7%	-5277.0%
Financial Health
Cash	$19M	$25M
Debt	$280M	$0
Net Cash/Debt	$-261M	$25M
Current Ratio (TTM)	0.34x	4.82x
Quick Ratio (TTM)	0.33x	4.64x
Debt/Equity (TTM)	4.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	1.92
52W Performance	83.9%	61.0%
YTD Performance	137.5%	92.7%
% from 52W High	-25.6%	-62.0%
% from 52W Low	183.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	-30.8%	-68.2%
Earnings Yield (TTM)	28.7%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AGEN research	View ZNTL research

Valuation

P/E Ratio

AGEN

3.45x

P/S Ratio

ZNTL

0.00x

AGEN

2.41x

EV/FCF

AGEN

-5.89x

ZNTL

-1.27x

Growth & revenue

Revenue Growth TTM

AGEN

30.5%

Forward Revenue Growth

ZNTL

447.5%

AGEN

-1.2%

Profitability & performance

Gross Margin

AGEN

99.5%

ZNTL

0.0%

ROE

AGEN

76.6%

ZNTL

-5277.0%

FCF Yield %

AGEN

-30.8%

ZNTL

-68.2%

52-Week Performance

AGEN

83.9%

ZNTL

61.0%

Detailed metrics comparison

AGEN

Agenus Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

AGEN$319M

ZNTL$188M

Enterprise Value

AGEN$580M

ZNTL$163M

Price

AGEN$7.67

ZNTL$2.64

P/E Ratio

AGEN3.45x

ZNTLN/A

P/S Ratio

AGEN2.41x

ZNTL0.00x

EV/Sales

AGEN4.37x

ZNTL0.00x

EV/EBITDA

AGEN13.66x

ZNTL0.00x

P/B Ratio

AGEN110.53x

ZNTL1.70x

P/FCF Ratio

AGENN/A

ZNTLN/A

EV/FCF

AGEN-5.89x

ZNTL-1.27x

PEG Ratio

AGENN/A

ZNTLN/A

Forward P/E (NTM)

AGENN/A

ZNTLN/A

Forward P/S (NTM)

AGEN3.37x

ZNTLN/A

Revenue (TTM)

AGEN$133M

ZNTL$0

Revenue Growth (YoY)

AGEN30.5%

ZNTLN/A

Forward Rev Growth

AGEN-1.2%

ZNTL447.5%

Gross Margin (TTM)

AGEN99.5%

ZNTL0.0%

Operating Margin (TTM)

AGEN103.2%

ZNTL0.0%

EBITDA Margin (TTM)

AGEN30.6%

ZNTL0.0%

Net Margin (TTM)

AGEN69.2%

ZNTL0.0%

FCF Margin (TTM)

AGEN-74.2%

ZNTLN/A

Net Income (TTM)

AGEN$92M

ZNTL$-62M

FCF (TTM)

AGEN$-99M

ZNTL$-128M

EPS (TTM)

AGEN$2.22

ZNTL$0.00

ROE (TTM)

AGEN76.6%

ZNTL-5277.0%

ROA (TTM)

AGEN44.9%

ZNTL-4055.0%

ROIC (TTM)

AGEN48.7%

ZNTL-5277.0%

Cash

AGEN$19M

ZNTL$25M

Debt

AGEN$280M

ZNTL$0

Net Cash/Debt

AGEN$-261M

ZNTL$25M

Current Ratio (TTM)

AGEN0.34x

ZNTL4.82x

Quick Ratio (TTM)

AGEN0.33x

ZNTL4.64x

Debt/Equity (TTM)

AGEN4.01x

ZNTL0.00x

Debt/Assets (TTM)

AGEN0.0%

ZNTL0.0%

Interest Coverage (TTM)

AGENN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

AGEN0.00x

ZNTL0.00x

Beta

AGEN1.50

ZNTL1.92

52W Performance

AGEN83.9%

ZNTL61.0%

YTD Performance

AGEN137.5%

ZNTL92.7%

% from 52W High

AGEN-25.6%

ZNTL-62.0%

% from 52W Low

AGEN183.0%

ZNTL117.8%

Asset Turnover (TTM)

AGEN0.65x

ZNTL0.00x

FCF Yield (TTM)

AGEN-30.8%

ZNTL-68.2%

Earnings Yield (TTM)

AGEN28.7%

ZNTL-32.9%

Dividend Yield (TTM)

AGENN/A

ZNTLN/A

Rule of 40

AGEN-43.8

ZNTL0.0

EV/GP/RG

AGENN/A

ZNTLN/A

Ticker research

View AGEN research View ZNTL research

Metric	AGEN Agenus Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$319M	$188M
Enterprise Value	$580M	$163M
Price	$7.67	$2.64
P/E Ratio	3.45x	N/A
P/S Ratio	2.41x	0.00x
EV/Sales	4.37x	0.00x
EV/EBITDA	13.66x	0.00x
P/B Ratio	110.53x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.89x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.37x	N/A
Revenue & Growth
Revenue (TTM)	$133M	$0
Revenue Growth (YoY)	30.5%	N/A
Forward Rev Growth	-1.2%	447.5%
Profitability
Gross Margin (TTM)	99.5%	0.0%
Operating Margin (TTM)	103.2%	0.0%
EBITDA Margin (TTM)	30.6%	0.0%
Net Margin (TTM)	69.2%	0.0%
FCF Margin (TTM)	-74.2%	N/A
Net Income (TTM)	$92M	$-62M
FCF (TTM)	$-99M	$-128M
EPS (TTM)	$2.22	$0.00
ROE (TTM)	76.6%	-5277.0%
ROA (TTM)	44.9%	-4055.0%
ROIC (TTM)	48.7%	-5277.0%
Financial Health
Cash	$19M	$25M
Debt	$280M	$0
Net Cash/Debt	$-261M	$25M
Current Ratio (TTM)	0.34x	4.82x
Quick Ratio (TTM)	0.33x	4.64x
Debt/Equity (TTM)	4.01x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.50	1.92
52W Performance	83.9%	61.0%
YTD Performance	137.5%	92.7%
% from 52W High	-25.6%	-62.0%
% from 52W Low	183.0%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.65x	0.00x
FCF Yield (TTM)	-30.8%	-68.2%
Earnings Yield (TTM)	28.7%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-43.8	0.0
EV/GP/RG	N/A	N/A
Ticker research	View AGEN research	View ZNTL research